226 related articles for article (PubMed ID: 32387861)
21. Total sesquiterpene glycosides from Loquat (Eriobotrya japonica) leaf alleviate high-fat diet induced non-alcoholic fatty liver disease through cytochrome P450 2E1 inhibition.
Jian T; Ao X; Wu Y; Lv H; Ma L; Zhao L; Tong B; Ren B; Chen J; Li W
Biomed Pharmacother; 2017 Jul; 91():229-237. PubMed ID: 28458161
[TBL] [Abstract][Full Text] [Related]
22. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.
Ou Q; Weng Y; Wang S; Zhao Y; Zhang F; Zhou J; Wu X
Dig Dis Sci; 2018 Dec; 63(12):3398-3408. PubMed ID: 30191499
[TBL] [Abstract][Full Text] [Related]
23. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
[TBL] [Abstract][Full Text] [Related]
24. Inflammation inhibition and gut microbiota regulation by TSG to combat atherosclerosis in ApoE
Li F; Zhang T; He Y; Gu W; Yang X; Zhao R; Yu J
J Ethnopharmacol; 2020 Jan; 247():112232. PubMed ID: 31606534
[TBL] [Abstract][Full Text] [Related]
25. Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats.
Ma Z; Chu L; Liu H; Wang W; Li J; Yao W; Yi J; Gao Y
Sci Rep; 2017 Mar; 7():44819. PubMed ID: 28300221
[TBL] [Abstract][Full Text] [Related]
26. Discovery of NAFLD-Improving Agents by Promoting the Degradation of Keap1.
Qi M; Zhong H; Cheng Z; Chen S; Xiao H; Shang J; Chen L; Sun J
J Med Chem; 2023 Jul; 66(13):9184-9200. PubMed ID: 37386884
[TBL] [Abstract][Full Text] [Related]
27. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism.
Zhou Y; Ding YL; Zhang JL; Zhang P; Wang JQ; Li ZH
Biomed Pharmacother; 2018 Jan; 97():1397-1408. PubMed ID: 29156529
[TBL] [Abstract][Full Text] [Related]
28. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.
Dwivedi DK; Jena GB
Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):705-716. PubMed ID: 31834465
[TBL] [Abstract][Full Text] [Related]
29. Tetrahydroxystilbene Glucoside Attenuates Oxidative Stress-Induced Aging by Regulating Oxidation Resistance and Inflammation in Larval Zebrafish.
Xia H; Cheng X; Cao M; Sun X; He F; Yao X; Liu H
Zebrafish; 2023 Apr; 20(2):55-66. PubMed ID: 37071853
[TBL] [Abstract][Full Text] [Related]
30. 2,3,5,4'-tetrahydroxy-stilbene-2-O-β-D-glucoside ameliorates NAFLD via attenuating hepatic steatosis through inhibiting mitochondrial dysfunction dependent on SIRT5.
Zhang S; Wu Z; Shi L; Yan S; Huang Z; Lu B; Wang Z; Ji L
Phytomedicine; 2022 May; 99():153994. PubMed ID: 35220131
[TBL] [Abstract][Full Text] [Related]
31. Combination of Hypertension Along with a High Fat and Cholesterol Diet Induces Severe Hepatic Inflammation in Rats via a Signaling Network Comprising NF-κB, MAPK, and Nrf2 Pathways.
Yuan Y; Naito H; Jia X; Kitamori K; Nakajima T
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906458
[TBL] [Abstract][Full Text] [Related]
32. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-d-glucoside alleviated the acute hepatotoxicity and DNA damage in diethylnitrosamine-contaminated mice.
Yu W; Zhao J; Li W; Zheng Y; Zhu J; Liu J; Liu R; Wang Z; Wang X; Hai C
Life Sci; 2020 Feb; 243():117274. PubMed ID: 31927046
[TBL] [Abstract][Full Text] [Related]
33. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway.
Chen M; Xing J; Pan D; Peng X; Gao P
Biomed Pharmacother; 2020 Aug; 128():110286. PubMed ID: 32521450
[TBL] [Abstract][Full Text] [Related]
34. Tetrahydroxystilbene glucoside ameliorates diabetic nephropathy in rats: involvement of SIRT1 and TGF-β1 pathway.
Li C; Cai F; Yang Y; Zhao X; Wang C; Li J; Jia Y; Tang J; Liu Q
Eur J Pharmacol; 2010 Dec; 649(1-3):382-9. PubMed ID: 20854812
[TBL] [Abstract][Full Text] [Related]
35. Aescin can alleviate NAFLD through Keap1-Nrf2 by activating antioxidant and autophagy.
Yu H; Yan S; Jin M; Wei Y; Zhao L; Cheng J; Ding L; Feng H
Phytomedicine; 2023 May; 113():154746. PubMed ID: 36905866
[TBL] [Abstract][Full Text] [Related]
36. Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-kappaB pathways and inhibition of intracellular ROS/RNS generation.
Wang T; Gu J; Wu PF; Wang F; Xiong Z; Yang YJ; Wu WN; Dong LD; Chen JG
Free Radic Biol Med; 2009 Aug; 47(3):229-40. PubMed ID: 19272442
[TBL] [Abstract][Full Text] [Related]
37. Punicalagin, a Pomegranate-Derived Ellagitannin, Suppresses Obesity and Obesity-Induced Inflammatory Responses Via the Nrf2/Keap1 Signaling Pathway.
Kang B; Kim CY; Hwang J; Jo K; Kim S; Suh HJ; Choi HS
Mol Nutr Food Res; 2019 Nov; 63(22):e1900574. PubMed ID: 31444955
[TBL] [Abstract][Full Text] [Related]
38. A novel shogaol analog suppresses cancer cell invasion and inflammation, and displays cytoprotective effects through modulation of NF-κB and Nrf2-Keap1 signaling pathways.
Gan FF; Ling H; Ang X; Reddy SA; Lee SS; Yang H; Tan SH; Hayes JD; Chui WK; Chew EH
Toxicol Appl Pharmacol; 2013 Nov; 272(3):852-62. PubMed ID: 23899529
[TBL] [Abstract][Full Text] [Related]
39. Epigallocatechin-3-gallate prevents TNF-α-induced NF-κB activation thereby upregulating ABCA1 via the Nrf2/Keap1 pathway in macrophage foam cells.
Jiang J; Mo ZC; Yin K; Zhao GJ; Lv YC; Ouyang XP; Jiang ZS; Fu Y; Tang CK
Int J Mol Med; 2012 May; 29(5):946-56. PubMed ID: 22367622
[TBL] [Abstract][Full Text] [Related]
40. Investigation on the mechanism of 2,3,4',5-Tetrahydroxystilbene 2-o-D-glucoside in the treatment of inflammation based on network pharmacology.
Sun L; Wang B; Sun T; Zhou F; Zhu B; Li C; Wan H; Ding Z
Comput Biol Med; 2022 Jun; 145():105448. PubMed ID: 35364310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
